Stockreport

Exclusive-Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say [Yahoo! Finance]

Inhibrx Biosciences, Inc.  (INBX) 
PDF KGaA and Japan's Ono Pharmaceutical for an experimental cancer treatment that could be valued at more than $8 billion, people familiar with the matter said. The San ?D [Read more]